MRD in ASC samples linked to high risk of relapse post-ASCT in R/R DLBCL

02.07.23

MRD in ASC samples linked to high risk of relapse post-ASCT in R/R DLBCL

by ASTCT Science Highlights

Detectable MRD Associated with Increased Relapse Risk in AML Patients Treated With RIC, But Not MAC, Before Allo-HCT

02.02.23

Detectable MRD Associated with Increased Relapse Risk in AML Patients Treated With RIC, But Not MAC, Before Allo-HCT

by Eleanor Mayfield, ELS

Study Suggests Possible Therapeutic Role for Inhibition of B-Catenin and FOXO3 Expression

01.23.23

Study Suggests Possible Therapeutic Role for Inhibition of B-Catenin and FOXO3 Expression

by Eleanor Mayfield, ELS

FLT3-ITD MRD “Is a Strong Independent Prognostic Factor for Relapse and Death” in AML

01.18.23

FLT3-ITD MRD “Is a Strong Independent Prognostic Factor for Relapse and Death” in AML

by Eleanor Mayfield, ELS

Plant-Based Diet, Butyrate Production “Associated With Sustained MRD Negativity in Multiple Myeloma

12.06.22

Plant-Based Diet, Butyrate Production “Associated With Sustained MRD Negativity in Multiple Myeloma

by Eleanor Mayfield, ELS

UCART19 for adults with r/r B-ALL

11.24.22

UCART19 for adults with r/r B-ALL

by ASTCT Science Highlights

HCT-CI score impact on NMA HSCT outcome for older AML patients

11.08.22

HCT-CI score impact on NMA HSCT outcome for older AML patients

by ASTCT Science Highlights

TECing a Closer Look at Teclistamab with Dr. Saad Usmani

09.15.22

TECing a Closer Look at Teclistamab with Dr. Saad Usmani

by Rahul Banerjee, MD, FACP

MRD Positivity in Two IDH Variants Associated with Higher Post-HSCT Relapse Risk in Patients with AML

05.25.22

MRD Positivity in Two IDH Variants Associated with Higher Post-HSCT Relapse Risk in Patients with AML

by ASTCT

Theme picker